BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29309634)

  • 1. Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother-infant pairs.
    Waitt C; Olagunju A; Nakalema S; Kyohaire I; Owen A; Lamorde M; Khoo S
    J Antimicrob Chemother; 2018 Apr; 73(4):1013-1019. PubMed ID: 29309634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.
    Mugwanya KK; Hendrix CW; Mugo NR; Marzinke M; Katabira ET; Ngure K; Semiyaga NB; John-Stewart G; Muwonge TR; Muthuri G; Stergachis A; Celum CL; Baeten JM
    PLoS Med; 2016 Sep; 13(9):e1002132. PubMed ID: 27676257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC-MS/MS.
    Waitt C; Diliiy Penchala S; Olagunju A; Amara A; Else L; Lamorde M; Khoo S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():300-307. PubMed ID: 28651173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi.
    Palombi L; Pirillo MF; Marchei E; Jere H; Sagno JB; Luhanga R; Floridia M; Andreotti M; Galluzzo CM; Pichini S; Mwenda R; Mancinelli S; Marazzi MC; Vella S; Liotta G; Giuliano M
    J Antimicrob Chemother; 2016 Apr; 71(4):1027-30. PubMed ID: 26679247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots.
    Olagunju A; Amara A; Waitt C; Else L; Penchala SD; Bolaji O; Soyinka J; Siccardi M; Back D; Owen A; Khoo S
    J Antimicrob Chemother; 2015 Oct; 70(10):2816-22. PubMed ID: 26108608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of an LC-MS/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spots.
    Schauer AP; Sykes C; Cottrell ML; Prince H; Kashuba ADM
    J Pharm Biomed Anal; 2018 Feb; 149():40-45. PubMed ID: 29100029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy.
    Mirochnick M; Thomas T; Capparelli E; Zeh C; Holland D; Masaba R; Odhiambo P; Fowler MG; Weidle PJ; Thigpen MC
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1170-6. PubMed ID: 19114673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interactions between lersivirine and zidovudine, tenofovir disoproxil fumarate/emtricitabine and abacavir/lamivudine.
    Vourvahis M; Davis J; Langdon G; Layton G; Fang J; Choo HW; Hansson AG; Tawadrous M
    Antivir Ther; 2013; 18(6):745-54. PubMed ID: 23558061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and Breast Milk Pharmacokinetics of Tenofovir Disoproxil Fumarate in Nursing Mother with Chronic Hepatitis B-Infant Pairs.
    Erturk US; Mete B; Ozaras R; Saltoglu N; Balkan II; Mert A; Kacmaz B; Saglam O; Guney B; Sayman OA; Tabak F
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0111021. PubMed ID: 34310204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection.
    Kayes T; Crane H; Symonds A; Dumond J; Cottrell M; Di Girolamo J; Manandhar S; Lim TH; Gane E; Kashuba A; Levy MT
    Aliment Pharmacol Ther; 2022 Aug; 56(3):510-518. PubMed ID: 35599363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boosted darunavir, emtricitabine and tenofovir pharmacokinetics in sthe early and late postgastric bypass surgery periods.
    Baettig V; Courlet P; Delko T; Battegay M; Marzolini C
    AIDS; 2018 Aug; 32(13):1903-1905. PubMed ID: 30045058
    [No Abstract]   [Full Text] [Related]  

  • 12. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
    Ugwu EO; Eleje GU; Ugwu AO; Nwagha UI; Ikechebelu JI; Umeh UA; Okafor HU
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013653. PubMed ID: 37306558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants.
    Fogel JM; Taha TE; Sun J; Hoover DR; Parsons TL; Kumwenda JJ; Mofenson LM; Fowler MG; Hendrix CW; Kumwenda NI; Eshleman SH; Mirochnick M
    J Acquir Immune Defic Syndr; 2012 Aug; 60(5):462-5. PubMed ID: 22614899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of tenofovir in breast milk support breastfeeding in HBV-infected mothers treated with tenofovir disoproxil fumarate.
    Li S; Jin J; Jiang Y; Shi J; Jiang X; Lin N; Ma Z
    Int J Antimicrob Agents; 2023 Mar; 61(3):106726. PubMed ID: 36646229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HIV-1: 48 week results of a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
    Molina JM; Ward D; Brar I; Mills A; Stellbrink HJ; López-Cortés L; Ruane P; Podzamczer D; Brinson C; Custodio J; Liu H; Andreatta K; Martin H; Cheng A; Quirk E
    Lancet HIV; 2018 Jul; 5(7):e357-e365. PubMed ID: 29925489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life.
    Mirochnick M; Taha T; Kreitchmann R; Nielsen-Saines K; Kumwenda N; Joao E; Pinto J; Santos B; Parsons T; Kearney B; Emel L; Herron C; Richardson P; Hudelson SE; Eshleman SH; George K; Fowler MG; Sato P; Mofenson L;
    J Acquir Immune Defic Syndr; 2014 Jan; 65(1):33-41. PubMed ID: 23979002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.
    Castillo-Mancilla JR; Zheng JH; Rower JE; Meditz A; Gardner EM; Predhomme J; Fernandez C; Langness J; Kiser JJ; Bushman LR; Anderson PL
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):384-90. PubMed ID: 22935078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy.
    Lê MP; Landman R; Koulla-Shiro S; Charpentier C; Sow PS; Diallo MB; Ngom Gueye NF; Ngolle M; Le Moing V; Eymard-Duvernay S; Benalycherif A; Delaporte E; Girard PM; Peytavin G;
    J Antimicrob Chemother; 2015 May; 70(5):1517-21. PubMed ID: 25583749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic levels of lopinavir in late pregnancy and abacavir passage into breast milk in the Mma Bana Study, Botswana.
    Shapiro RL; Rossi S; Ogwu A; Moss M; Leidner J; Moffat C; Lockman S; Moyo S; Makhema J; Essex M; Capparelli E
    Antivir Ther; 2013; 18(4):585-90. PubMed ID: 23183881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.